A clinical trial in Chinese public hospitals is showing promise, but experts stress that further studies are needed.

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

This BCI technology breakthrough enables the patient to convert their thoughts into Chinese texts on computer for ...

Nevrargenics who are behind a drug which they believe not only stops the impact of MND but reverses the damage already done.

Mackenzie Wright joined a clinical trial that is bringing hope to Down syndrome families who have struggled with sudden, ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

Saman Gunatilake Emeritus Professor of Medicine and Neurologist University of Sri Jayewardenepura Key facts * Substandard and ...

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

People suffering from the disease are being given access to a revolutionary drug that's being hailed as a potential cure.

Discover a study that highlights that both the 2-dose and 3-dose HepB-CpG regimens provide better seroprotection compared to ...